[go: up one dir, main page]

NZ232826A - Leukaemia inhibitory factor (lif) and its effects on bone metabolism - Google Patents

Leukaemia inhibitory factor (lif) and its effects on bone metabolism

Info

Publication number
NZ232826A
NZ232826A NZ232826A NZ23282690A NZ232826A NZ 232826 A NZ232826 A NZ 232826A NZ 232826 A NZ232826 A NZ 232826A NZ 23282690 A NZ23282690 A NZ 23282690A NZ 232826 A NZ232826 A NZ 232826A
Authority
NZ
New Zealand
Prior art keywords
lif
effects
inhibitory factor
bone metabolism
leukaemia inhibitory
Prior art date
Application number
NZ232826A
Other languages
English (en)
Inventor
Donald Metcalf
Ian Reginald Reid
Thomas John Martin
Original Assignee
Amrad Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amrad Corp Ltd filed Critical Amrad Corp Ltd
Publication of NZ232826A publication Critical patent/NZ232826A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • A61K38/2093Leukaemia inhibitory factor [LIF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ232826A 1989-03-07 1990-03-07 Leukaemia inhibitory factor (lif) and its effects on bone metabolism NZ232826A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ309189 1989-03-07
AUPJ474289 1989-06-15

Publications (1)

Publication Number Publication Date
NZ232826A true NZ232826A (en) 1992-09-25

Family

ID=25643646

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ232826A NZ232826A (en) 1989-03-07 1990-03-07 Leukaemia inhibitory factor (lif) and its effects on bone metabolism

Country Status (5)

Country Link
EP (1) EP0463004A4 (xx)
JP (1) JP3055802B2 (xx)
CA (1) CA2048673A1 (xx)
NZ (1) NZ232826A (xx)
WO (1) WO1990010454A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97779A (en) * 1990-04-10 2000-01-31 Genentech Inc Compositions for cytoprotection against radiation and chemotherapy injury or risk thereof
WO1994021272A1 (en) * 1993-03-17 1994-09-29 Amrad Corporation Limited A method for treating microbial infection in an animal by administering a composition comprising lif and a cytokine
DE60009525T2 (de) * 1999-09-30 2005-02-03 Kaken Pharmaceutical Co., Ltd. Herstellung eines medikamentes zur verbesserten heilung des sternums nach einer sternotomie
US10512708B2 (en) 2013-03-07 2019-12-24 Case Western Reserve University Bioadhesive hydrogels
US11273236B2 (en) 2016-09-07 2022-03-15 Case Western Reserve University Engineered tissue constructs
EP3551199A4 (en) * 2016-12-11 2020-07-22 Case Western Reserve University COMPOSITIONS AND METHODS OF MODULATION OF ENDOCHONDRAL OSSIFICATION AND BONE FORMATION
WO2019040224A1 (en) 2017-08-21 2019-02-28 Case Western Reserve University HYDROGEL FOR TISSUE ENGINEERING AND BIO-PRINTING
US20190298883A1 (en) 2018-03-30 2019-10-03 Case Western Reserve University Insoluble native collagen fibers and their use in cell aggregates and tissue constructs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438032A (en) * 1981-01-30 1984-03-20 The Regents Of The University Of California Unique T-lymphocyte line and products derived therefrom
US4675295A (en) * 1981-10-28 1987-06-23 Denki Kagaku Kogyo Kabushiki Kaisha Process for producing subculturable lymphokine-producing human T cell hybridomas
AU609128B2 (en) * 1987-04-02 1991-04-26 Amrad Operations Pty. Limited Leukaemia-inhibitory factor

Also Published As

Publication number Publication date
JP3055802B2 (ja) 2000-06-26
JPH04503958A (ja) 1992-07-16
EP0463004A4 (en) 1992-04-01
WO1990010454A1 (en) 1990-09-20
EP0463004A1 (en) 1992-01-02
CA2048673A1 (en) 1990-09-08

Similar Documents

Publication Publication Date Title
GB8830152D0 (en) Cooled turbomachinery components
EP0285448A3 (en) Leukaemia inhibitory factor
GB8904696D0 (en) Electronic locker system
HU903399D0 (en) Cryosurgical device
DK0387885T3 (da) Direkte kompressionscholostyramintablet og opløsningsmiddelfri coating dertil
EP0414405A3 (en) Aligned slideholder and slide assembly
NZ232826A (en) Leukaemia inhibitory factor (lif) and its effects on bone metabolism
IL93708A (en) Joule-thomson cooler
EP0415246A3 (en) Electronic rack
GB9004890D0 (en) Leukaemia inhibitory factor
GB9018760D0 (en) Integrated circuit and its connecting circuit
EP0421603A3 (en) Melt-processable copolyesterimide
GB2216180B (en) Cabinet
GB9003629D0 (en) Jig and jig arrangement
AU6282090A (en) Analog multiplying-averaging circuit and wattmeter circuit using the circuit
GB2236203B (en) Calculation method and calculator using the same
ZA901746B (en) Metabolic effects of leukaemia inhibitory factor on bone
GB2231408B (en) Sampling circuits
GB2214743B (en) Sample and hold circuit
GB8919861D0 (en) Shelf
GB2259635B (en) Oscilloscope
ZA911096B (en) (2-imidazolin-2-ylamino)tetrahydro-quinoxalines and methods for using same
GB2226726B (en) Sample and hold circuit
ZA882277B (en) Leukaemia inhibitory factor
IE891418L (en) Fluoroavermectins and fluoromilbemycins

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)